Bafo Technologies Corp. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2018
November 07, 2018 at 11:43 am EST
Share
BAFO Technologies Corp. announced earnings results for the third quarter and nine months ended September 30, 2018. For the third quarter, the company announced sales was TWD 107.656 million compared to TWD 108.658 million a year ago. Operating income was TWD 16.150 million compared to TWD 12.310 million a year ago. Net income was TWD 12.771 million compared to TWD 63.507 million a year ago. Basic earnings per share was TWD 0.58 compared to TWD 2.86 a year ago. Diluted earnings per share was TWD 0.57 compared to TWD 2.85 a year ago.
For the nine months, sales was TWD 372.971 million compared to TWD 352.402 million a year ago. Operating income was TWD 68.052 million compared to TWD 55.352 million a year ago. Net income was TWD 56.167 million compared to TWD 103.548 million a year ago. Basic earnings per share was TWD 2.53 compared to TWD 4.66 a year ago. Diluted earnings per share was TWD 2.52 compared to TWD 4.63 a year ago.
Li Kang Biomedical Co., Ltd. formerly BAFO TECHNOLOGIES CORP., is engaged in the manufacture and sale of computer, communication and consumer (3C) product cables and circumscribed computer peripheral products, as well as communication products. The Company offers unshielded twisted pair (UTP) cables, monitor cables, small computer system interface (SCSI) cables, universal serial bus (USB) cables, wireless hopping/mesh access points, wireless modules, and wireless vehicle communication systems, among others. The Company distributes its products within the domestic market and to overseas markets, including Europe, the Americas and the rest of Asia.
LI KANG BIOMEDICAL CO., LTD. 
